Shortly after laying out $75 million upfront for Corstasis Therapeutics and its congestive heart failure edema drug Enbumyst, Esperion Therapeutics is itself being acquired and taken private by healthcare investment firm Archimed.
The real estate market has been stagnant for two consecutive years due to soaring mortgage rates, leading to a decrease in homeownership and a decrease in …
A Massachusetts regulator is warning that CVS and Mass General Brigham’s proposed MinuteClinic partnership could drive up healthcare spending by at least $40 million annually, largely …
President Trump has repeatedly attacked German Chancellor Friedrich Merz for comments he made about the U.S. role in the Iran war, targeting a leader who has …